Skip to Main Content

Veteran Cowen biotech analyst Eric Schmidt is joining Allogene Therapeutics, the new CAR-T cancer therapy startup, as its chief financial officer.

The formal announcement was made Monday in a joint statement issued by Allogene and Cowen. Arie Belldegrun, the former Kite Pharma CEO and now co-founder and chairman of Allogene, had been recruiting Schmidt for some time, as previously reported by STAT in May.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!